Comparison 11. Therapeutic ultrasound plus nerve and tendon gliding exercise plus night splint plus activity modification versus placebo iontophoresis plus nerve and tendon gliding exercises plus night splint plus activity modification.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Short‐term improvement in CTS symptoms (BCTQ symptom severity score) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
1.1 End of treatment (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
1.2 Three months post‐treatment cessation (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
2 Short‐term improvement in CTS symptoms (VAS pain on movement) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
2.1 Change from baseline to end of treatment	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
3 Short‐term improvement in CTS symptoms (VAS pain at rest) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
3.1 Change from baseline to end of treatment	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
4 Short‐term improvement in CTS symptoms (VAS pain at night) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
4.1 Change from baseline to end of treatment	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
5 Short‐term improvement in functional ability (BCTQ functional status score) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
5.1 End of treatment (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
5.2 Three months post‐treatment cessation (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
6 Short‐term improvement in functional ability (Health Assessment Questionnaire) (3 months or less)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
6.1 End of treatment (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
6.2 Three months post‐treatment cessation (endpoint values)	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]